Clinical trial
Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting
NCT00412425 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00412425 |
|---|---|
| Title | Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting |
| Official title | Evaluation of Two Different Schedules of Palonosetron for the Prevention of Nausea and Vomiting in Patients With Metastatic Melanoma Receiving Concurrent Biochemotherapy |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | Eisai Inc. Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Melanoma |
| Intervention type | Drug |
| Interventions | Palonosetron |
| Enrollment | 30 |
| Start date | Nov 1, 2006 |
| Primary completion | May 1, 2009 |
| Completion | May 1, 2009 |
| First posted | Dec 18, 2006 |
| Last update posted | May 4, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: